Delayed death from pulmonary tuberculosis: Unsuspected subtherapeutic drug levels

Southern Medical Journal

Volumn 93, Issue 5, 2000, Pages 507-510

  Morehead, Richard S ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ADULT; ARTICLE; CASE REPORT; COMORBIDITY; CRITICAL ILLNESS; DEATH; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LUNG TUBERCULOSIS; MALABSORPTION; VIRUS DETECTION;

EID: 0034042565     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200093050-00015     Document Type: Article

References (25)

1. Pablos-Mendez A, Sterling TR, Frieden TR: The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 1996; 276:1223-1228
2. Zafran N, Heldal E, Pavlovic S, et al: Why do our patients die of active tuberculosis in the era of effective therapy? Tuberc Lung Dis 1994; 75:329-333
3. Chapman R, Claydon S: Mycobacterium tuberculosis: a continuing cause of sudden and unexpected death in west London. J Clin Pathol 1992; 45:713-715
4. Bobrowitz I: Active tuberculosis undiagnosed until autopsy. Am J Med 1982; 72:650-658
5. Xie H, Enarson D, Chao C, et al: Deaths in tuberculosis patients in British Columbia, 1980-1984. Tuberc Lung Dis 1992; 73:77-82
6. Cullinan P, Meredith S: Deaths in adults with notified pulmonary tuberculosis 1983-5. Thorax 1991; 40:347-350
7. Nisar M, Davies P: Current trends in tuberculosis mortality in England and Wales. Thorax 1991; 46:383-340
8. Sacks L, Pendle S: Factors related to in-hospital deaths in patients with tuberculosis. Arch Intern Med 1998; 158:1916-1922
9. Ellis M, Webb A: Cause of death in patients admitted to hospital for pulmonary tuberculosis. Lancet 1983; 1:665-667
10. Jindani A, Aber V, Edwards E, et al: The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 1980; 121:939-949
11. Hobby G, Holman A, Iseman M, et al: Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agent Chemother 1973; 4:94-104
12. Morris CD: The duration of excretion of viable bacilli in elderly patients on treatment for cavitating pulmonary tuberculosis. S Afr Med J 1996; 86:958-960
13. Rouillon A, Perdrizet S, Parrot R: Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 1976; 57:275-299
14. Gordon S, Horsburgh C, Peloquin C, et al: Low serum levels of oral antimyobacterial agents in patients with disseminated Mycobacterium avium complex disease. J Inject Dis 1993; 168:1559-1562
15. Peloquin C, MacPhee A, Berning S: Malabsorption of antimycobacterial medications. N Engl J Med 1992; 329:1122-1123
16. Sahai J, Gallicano K, Swick L, et al: Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection. Ann Intern Med 1997; 127:289-293
17. Berning S, Huitt G, Iseman M, et al: Malabsorption of antituberculosis medications by a patient with AIDS. N Engl J Med 1992; 327:1817-1818
18. Barakat M, Scott J, Hughes J, et al: Grand rounds - Hammersmith Hospital, persistent lever in pulmonary tuberculosis (clinical conference). BMJ 1996; 313:1543-1545
19. Kimerling M, Phillips P, Patterson P, et al: Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patient. Chest 1998; 113:1178-1183
20. Manela F: Tuberculous enteritis. Tuberculosis and Nontuberculous Mycobacterial Infections. Schlossberg D (ed). Philadelphia, WB Saunders Co, 4th Ed, 1999, pp 229-233
21. Parsons R, Hossack G, Paddock G: The absorption of antibiotics in adult patients with coeliac disease. J Antimicrob Chemother 1975; 1:39-50
22. Peloquin C: Using therapeutic drug monitoring to dose the antimycobacterial drugs. Clin Chest Med 1997; 18:79-87
23. Thompson J: The intestinal response to critical illness. Am J Gastroenterol 1995; 90:129-200
24. Berte S, DiMase J, Christianson C: Isoniazid, para-aminosalicylic acid, and streptomycin intolerance in 1,744 patients. Am Rev Respir Dis 1964; 90:598-606
25. Muthuswamy P, Hu T, Carasso B, et al: Prednisone as adjunctive therapy in the management of pulmonary tuberculosis, report of 12 cases and review of the literature. Chest 1995; 107:1621-1630